School of Molecular Biosciences

Galen, the animal care facility manager for SMB, is not only in charge of the day-to-day operations of the animal facilities but he also provides instruction to his staff about animal husbandry, oversight of equipment maintenance and advice to faculty on breeding habits and other factors that potentially could affect research data. Gorence has displayed outstanding ability and worked extra hours to accommodate a construction project that required moving animals and equipment and decontaminating facilities. He is applauded for his anticipation of problems and solutions in a way that causes minimal disruption to research.  He will be honored at the Celebrating Excellence Recognition Banquet on March 28, as part of the Washington State University  annual Showcase celebration.

Interim Provost Bernardo and Interim VP for Research Magnuson have provided substantial funds to support service agreements for several highly used instrument in the Laboratory for Biotechnology and Bioanalysis, Dr. Griswold, Director of the Laboratory, announced today. These monies affirm the commitment of the institution to the Laboratory which is used by numerous research labs on the WSU campus. Dr. Jones, Director of SMB, thanks Dr. Griswold and the staff of the Laboratory for their exemplary service and efforts on behalf of the user base of this important and outstanding core.  

“Nanomedicine Nature of Homeopathic Medicines for Cancer: Developmental Project” Lotte and John Hecht Memorial Foundation - Jan 2014 - Jan 2016
The Foundation supports research in complimentary and alternative medicine (CAM).  Prevailing hypothesis of the efficacy of homeopathic remedies is that the way they are prepared results in nanoparticles with the drug molecules embedded in them.  This facilitates ready cell transport and targeted delivery of drugs to diseased cells.  The focus of my project will be to embed specific homeopthic drugs that have shown efficacy for glioblastoma in nanoparticles of slilca and calcium phosphate in a controlled manner and and study their interaction with glioma cells.  The goal is to understand the nanomedicine-cell interaction at the molecular level and propose possible mechanism of the action of these drugs.  The initial focus will be on mitochondrial DNAs that upregulate metabolic pathways considered to be key in glioma cell proliferation.

Dr. Reeves will present the distinguished faculty address as part of the 2014 Showcase celebration of Washington State University research, scholarship and creative work.  The address will be at 3:30 p.m. Thursday, March 27, in the science forum on the third floor of the Veterinary and Biomedical Research Building.
This annual award from Washington State University recognizes a faculty member whose achievements in research, scholarship and teaching place him or her in the front ranks of his or her discipline. Reeves is one of the most highly cited scientists at WSU and in 2010 was elected a Fellow of the American Association for the Advancement of Science for contributions to the field of chromatin research, particularly for studies elucidating the structure and function of the HMGA family of non-histone architectural proteins.  http://news.wsu.edu/2014/02/04/reeves-will-present-distinguished-faculty-address/